loader2
Partner With Us NRI

Concord Drugs Ltd share Price Today

Company details

37.40
40.00
25.56
61.50
6M Return 18.18%
1Y Return 30.00%
Mkt Cap.(Cr) 39.00
Volume 30,166
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 30,166

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Concord Drugs Ltd shares SWOT Analysis

Strengths (4)

  • Company with Low Debt
  • Book Value per share Improving for last 2 years
  • Company with Zero Promoter Pledge

Weakness (7)

  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years
  • Degrowth in Revenue and Profit

Opportunity (2)

  • Results Screener: Stocks with upcoming results which are seeing positive shifts in share price
  • RSI indicating price strength

Threats (2)

  • Companies with growing costs YoY for long term projects
  • High PE (PE > 40)

Resistance and support

R1 40.1
R2 40.9
R3 41.9
Pivot

39.17

S1 38.4
S2 37.4
S3 36.6
EMA SMA
37.1
37.7
38.3
37.4
36.9
37.0
40.9
38.2
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
LAKSHMI PRASANNA PALLETI Bulk Sell 2024-01-15 44.63 51994 BSE
MATALIA STOCK BROKING PRIVATE LIMITED Bulk Purchase 2023-12-29 58.36 59398 BSE
MATALIA STOCK BROKING PRIVATE LIMITED Bulk Sell 2023-12-29 57.71 59398 BSE
Name Category Shares
NAGI REDDY SEELAM PROMOTER 29.13%
MANOJ KUMAR REDDY SEELAM PROMOTER 16.28%
SEELAM KONI REDDY PROMOTER 10%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Concord Drugs Ltd Stocks COMPARISON

Financials( in Cr) Concord Drugs Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Zydus Lifesciences Ltd Divis Laboratories Ltd
Price 39.00 1,531.40 1,399.05 1,051.40 3,910.75
% Change 6.70 0.26 -0.54 5.45 0.47
Mcap Cr 39.00 367,434.16 112,954.68 105,795.44 103,818.29
Revenue TTM Cr 52.08 43,885.68 15,790.60 17,237.40 7,767.51
Net Profit TTM Cr 0.99 8,560.84 2,513.47 1,997.30 1,823.38
PE TTM 40.57 39.15 26.62 28.83 75.36
1 Year Return 30.00 60.69 51.61 103.07 19.36
ROCE 6.04 16.79 14.76 16.25 19.30
ROE 3.30 16.46 10.66 14.05 14.89
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 31.14 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 44,248.95 -31,659.16
LAST 3M 105,886.10 -43,482.14
LAST 6M 173,149.22 48,654.40
LAST 12M 264,707.07 127,969.33

Concord Drugs Ltd Information

Stock PE (TTM)
40.57
Promoter Holding
55.41%
Book Value
35.3996
ROCE
6.04%
ROE
3.3%
Description
  • Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The Company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.

Registered Address

Survey No 249 Brahmanapally V, Hayathnagar M, Ranga Reddy, Telangana, 501511

Tel : 91-40-24036379
Email : concorddrugsltd:gmail.com
Website : http://www.concorddrugs.in
Registrar

Aarthi Consultants Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 538965
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : XT
ISIN : INE858L01010

FAQ’s on Concord Drugs Ltd Shares

You can buy Concord Drugs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Concord Drugs Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 17, 2024 04:01 PM the closing price of Concord Drugs Ltd was Rs.39.00.

Market capitalization or market cap is determined by multiplying the current market price of a company�s shares with the total number of shares outstanding. As of May 17, 2024 04:01 PM, the market cap of Concord Drugs Ltd stood at Rs. 39.00.

The latest PE ratio of Concord Drugs Ltd as of May 17, 2024 04:01 PM is 40.57

The latest PB ratio of Concord Drugs Ltd as of May 17, 2024 04:01 PM is 0.91

The 52-week high of Concord Drugs Ltd share price is Rs. 61.50 while the 52-week low is Rs. 25.56

Download App

Download Our App

Play Store App Store
market app